Showing 1841-1850 of 2038 results for "".
- Tarsus Pharmaceuticals Presents Results of Atlas Study Demonstrating the Functional and Psychosocial Impact of Demodex Blepharitishttps://modernod.com/news/tarsus-pharmaceuticals-presents-results-of-atlas-study-demonstrating-the-functional-and-psychosocial-impact-of-demodex-blepharitis/2479161/Tarsus Pharmaceuticals announced data from its Demodex blepharitis clinical program presented at the virtual Association for Research in Vision and Ophthalmology (ARVO) 2021 Annual Meeting. Tarsus’ lead product candidate, TP-03, is a topical ophthalmic formulation of lotilaner, a well-characteriz
- Alcon Presents Highlights of ARVO 2021 Datahttps://modernod.com/news/alcon-presents-highlights-of-arvo-2021-data/2479149/Alcon will be presenting new data at the Association for Research in Vision and Ophthalmology (ARVO) Virtual Meeting (May 1-7). Presentations include data for the Systane iLux MGD Thermal Pulsation System, Precision1 daily disposable contact lenses, and a forthcoming reusable monthly contact lens
- Ocular Therapeutix to Present Preclinical and Clinical Data at ARVOhttps://modernod.com/news/ocular-therapeutix-to-present-preclinical-and-clinical-data-at-arvo/2479146/Ocular Therapeutix announced multiple scientific presentations at the Association for Research in Vision and Ophthalmology (ARVO) annual meeting. With the ARVO 2021 Annual Meeting being moved to a virtual format, video-recorded presentations are scheduled to become available online at ARVOLearn o
- Gyroscope Therapeutics Files Registration Statement for Proposed Initial Public Offering in the United Stateshttps://modernod.com/news/gyroscope-therapeutics-files-registration-statement-for-proposed-initial-public-offering-in-the-united-states/2479087/Gyroscope Therapeutics announced it has filed a registration statement on Form F-1 with the U.S. Securities and Exchange Commission (SEC) relating to a proposed initial public offering (IPO) in the United States. All American Depositary Shares (ADSS) to be sold in the proposed IPO will be
- Roche, Regeneron’s REGEN-COV Cuts Symptomatic COVID-19 by 81% Among Household Contactshttps://modernod.com/news/roche-regenerons-regen-cov-cuts-symptomatic-covid-19-by-81-among-household-contacts/2479071/Regeneron Pharmaceuticals and partner Roche reported positive results from a phase 3 study, showing that a subcutaneous formulation of the antibody cocktail REGEN-COV (casirivimab with imdevimab) reduced the risk and burden of COVID-19 among household contacts of SARS-CoV-2-
- LION Eye Group to Develop New Retail Stores in New Yorkhttps://modernod.com/news/lion-eye-group-to-develop-new-retail-stores-in-new-york/2479074/New York-based LION Eye Group announced its intent to move forward with “LION Express,” a state-of-the art, eyewear focused, retail optometric store. The group is currently scouting locations in Garden City, Huntington,
- NEI Joins Call for Standardization of Ophthalmic Imaging Deviceshttps://modernod.com/news/nei-joins-call-for-standardization-of-ophthalmic-imaging-devices/2479064/The National Eye Institute (NEI), part of the National Institutes of Health, is joining the American Academy of Ophthalmology (AAO) and others in calling for imaging device makers to standardize their data formatting. Such standardization is expected to enable comm
- Oasis Medical Launches Cyber Platform MY OASIS to Support Dry Eye Clinicshttps://modernod.com/news/oasis-medical-launches-cyber-platform-my-oasis-to-support-dry-eye-clinics/2479021/Oasis Medical is formally launching its new patented cyber platform MY OASIS at SECO International 2021, booth #722. MY OASIS is a cyber platform for eye care providers to build their brand as a dry eye resourc
- AdHawk Microsystems Launches AdHawk MindLink Eye Tracking Researchhttps://modernod.com/news/adhawk-microsystems-launches-adhawk-mindlink-eye-tracking-research/2479002/AdHawk Microsystems announced the launch of AdHawk MindLink wearable eye tracking system. AdHawk MindLink produces accurate eye movement data to provide deep insights into human behavior, ocular, and neurological health. Delivered in the form of lightweight and comfortable glasses, the AdHawk sys
- SIFI Receives Marketing Authorization for Ophthalmic Products in in Turkeyhttps://modernod.com/news/sifi-recevies-marketing-authorizations-for-ophthalmic-products-in-in-turkey/2478996/SIFI, has announced that the Turkish Medicines and Medical Devices Agency (TMMDA) has approved the transfer of marketing authorizations from its former local distributor to its wholly owned subsidiary SIFI İlaç A.S. The approvals cover different formulations of ophthalmic drugs Netira, Netildex,